Chd Lifescience Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
- Paid Up Capital ₹ 7.75 M
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.14 M
- Revenue Growth 17.42%
- Profit Growth -34.49%
- Ebitda -30.87%
- Net Worth 4.80%
- Total Assets -5.09%
About Chd Lifescience
Chd Lifescience Private Limited (CLPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 February 2012 and has a history of 12 years and 11 months. Its registered office is in Dharwad, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 7.75 M.
The company currently has active open charges totaling ₹9.14 M.
Sudhir Hanagandi, Kumar Kolar, Suresh Honkalse, and Four other members serve as directors at the Company.
Company Details
-
Location
Dharwad, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24301KA2012PTC062723
-
Company No.
062723
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Feb 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Chd Lifescience?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhir Hanagandi
|
Managing Director | 27-Feb-2012 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kumar Kolar
|
Director | 27-Feb-2012 | Current |
|
Suresh Honkalse
|
Director | 27-Feb-2012 | Current |
|
Venu Jagataph
|
Director | 27-Feb-2012 | Current |
|
Nikhil Kolar
|
Director | 27-Feb-2012 | Current |
|
Mallappa Kolar
|
Director | 27-Feb-2012 | Current |
|
Kadappa Kolar
|
Director | 27-Feb-2012 | Current |
Financial Performance of Chd Lifescience.
Chd Lifescience Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.42% increase. The company also saw a substantial fall in profitability, with a 34.49% decrease in profit. The company's net worth moved up by a moderate rise of 4.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chd Lifescience?
In 2021, Chd Lifescience had a promoter holding of 92.26% and a public holding of 7.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Howaderm Pharmaceuticals LlpSuresh Honkalse is a mutual person
Charges (Loans)
₹9.14 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.56 Cr
- Karnataka Bank Ltd. : 0.24 Cr
- Hdfc Bank Limited : 0.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 May 2022 | Hdfc Bank Limited | ₹1.09 M | Open |
| 14 Aug 2017 | Karnataka Bank Ltd. | ₹2.45 M | Open |
| 09 Jan 2014 | State Bank Of India | ₹5.61 M | Open |
How Many Employees Work at Chd Lifescience?
Chd Lifescience has a workforce of 17 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chd Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chd Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
